| Protocol Number |
Title |
1999CG016
|
D9902 A group wide protocol for collecting and banking pediatric cancer research specimens: An IRSG protocol CCG D9902 |
2004CG064
|
COG ARST0331: Vincristine, Dactinomycin, and Lower Doses of Cyclophosphamide With or Without Radiation Therapy for Patients with Newly Diagnosed Low-Risk Embryonal/Botryoid/Spindle Cell Rhabdomyosarcoma |
2005LS023
|
MT2004-30: Dose Escalation of Total Marrow Irradiation Added To An Alkylator-Intense Conditioning Regimen For Patients with High Risk or Relapsed Solid Tumors |
2005LS080
|
An Evaluation of PET CT Imaging as a Predictor of Response to Preoperative Chemotherapy for Soft Tissue Sarcoma |
2006CG003
|
COG AOST0331: A Randomized Trial of the European and American Osteosarcoma Study Group to Optimize Treatment Strategies for Resectable Osteosarcoma Based on Histological Response to Pre-Operative Chemotherapy |
2006CG033
|
COG ADVL0413: A Phase I Study of the RAF Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, NSC# 724772, IND# 69896) in Children with Refractory Solid Tumors or Refractory Leukemias |
2007CG010
|
COG ADVL0612: A Phase I Study of Sunitinib, an Oral Multi-Targeted Tyrosine Kinase Inhibitor, in Children with Refractory Solid Tumors |
2007CG038
|
COG ARST0531: Randomized Study of Vincristine, Dactinomycin, and Cyclophosphamide (VAC), versus VAC Alternating with Vincristine and Irinotecan for Patients with Intermediate Risk Rhabdoymyosarcoma |
2007CG096
|
ARST0332 - Risk-Based Treatment for Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) in Patients Under 30 Years of Age |
2007IS117
|
Amgen 20050252: A Phase I Study to Evaluate the Safety and Pharmacokinetics of Panitumumab in Children with Solid Tumors |
2007NT029
|
Genetic Epidemiology of Osteosarcoma |
2007NT123
|
2007-18R: Chronic GVHD Cohort Protocol |
2008CG030
|
ANBL0531 Response-and Biology-based Therapy for Intermediate-risk Neuroblastoma |
2008CG069
|
COG ADVL0714 "A Phase I Study of VEGF Trap (NSC# 724770, IND #100137) in Children with Refractory Solid Tumors" |
2008IS028
|
A Study to Determine the Activity of SCH 717454 in Subjects with Osteosarcoma or Ewing's Sarcoma that has Relapsed After Standard Systemic Therapy |
2008IS067
|
A Pivotal Trial to Determine the Efficacy and Safety of AP23573 When Administered as Maintenence Therapy to Patients with Metastatic Soft Tissue or Bone Sarcomas |
2008IS086
|
MT2008-26: Defibrotide for Hematopoietic Stem Cell Transplant (SCT) Patient With Severe Hepatic Veno-occlusive Disease (VOD): A Treatment IND Study (Under CFR 312.34) |
2008NTCG058
|
COG AEWS07B1 A Children's Oncology Group Protocol for Collecting and Banking Ewing Sarcoma Specimens |
2008NTCG085
|
COG AOST06B1 A Children's Oncology Group Protocol for Collecting and Banking Osteosarcoma Specimens |
2008NTCG101
|
COG ANBL00B1 "Neuroblastoma Biology Studies" |
2008NTCG161
|
COG ACCL0731 Glutamic Acid to Decrease Vincristine Toxicity in Children with Cancer |
2009CG014
|
COG ADVL0821 A Phase II Study of IMC-A12 (Anti-IGF-I Receptor Monoclonal Antibody, IND# 100947, NSC# 742460) in Children With Relapsed/Refractory Solid Tumors |
2009NTCG017
|
COG ACCL0431 A Randomized Phase III Study of Sodium Thiosulfate for the Prevention of Cisplatin-Induced Ototoxicity in Children |
Clinical Trials Help